An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma
Clinical trial NCT04136808 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04136808
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.